ALLA GUENIN: Open Payments
NPI 1275802324 · SALEM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 10 payments from 8 companies in 2025. Trend: 2023 $210 · 2024 $247 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $212 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Indivior Inc. | 1 | $29 |
| REVANCE THERAPEUTICS, INC. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Viatris Specialty LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $15 |
Products named: AIRSUPRA, BREZTRI, JARDIANCE, LEQVIO, SUBLOCADE, DAXXIFY, MOUNJARO, YUPELRI.
Industry payments across MA — which companies pay providers there.
